Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (USA)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Platelet Based Equipment Supplied In USA
4 equipment items found
Manufactured by:Cellphire Therapeutics, Inc. based inRockville, MARYLAND (USA)
The basis of Cellphire’s technology is derived from nature. There are plants and animals able to withstand the loss of water caused by severe heat or cold by making the sugar trehalose, which replaces the water that evaporates over time. Once re-exposed to a humid atmosphere or water, they “come back to life” and are fully ...
Manufactured by:Cellphire Therapeutics, Inc. based inRockville, MARYLAND (USA)
Cellphire Therapeutics is committed to transforming hemostasis management with innovative products that fill critical gaps in the treatment of bleeding patients. Our lead clinical-stage candidate, Thrombosomes, is an activated platelet-based hemostatic. The product is currently in a Phase 2 clinical trial in bleeding thrombocytopenic patients. Thrombosomes has ...
Manufactured by:Verax Biomedical, Incorporated based inMarlborough, MASSACHUSETTS (USA)
The Company’s first product is the Platelet PGD Test for the detection of bacterial contamination in platelets. It is the only rapid test cleared by the FDA as a Safety Measure for leukoreduced apheresis platelets in plasma, or platelet additive solution as well as prestorage pooled platelets within 24 hours prior to transfusion. Other tests for the detection of bacteria are typically ...
by:VetStem Biopharma based inPoway, CALIFORNIA (USA)
The principle is to accelerate lagging internal healing processes by amplifying the biological signals that would naturally occur when platelets aggregate at a site of injury. By concentrating platelets and releasing more of those growth factors than would naturally occur – the intended effect is to attract stem cells and stimulate local tissue repair ...